Afya (NASDAQ:AFYA) Cut to Hold at Wall Street Zen

Wall Street Zen lowered shares of Afya (NASDAQ:AFYA) from a buy rating to a hold rating in a research report sent to investors on Saturday,Wall Street Zen reports.

Other analysts have also recently issued research reports about the stock. Bradesco Corretora upgraded shares of Afya to an “outperform” rating and set a $17.00 price target on the stock in a report on Thursday, September 24th. Zacks Research upgraded shares of Afya from a “strong sell” rating to a “hold” rating in a report on Monday, October 5th. JPMorgan Chase & Co. upgraded shares of Afya from a “neutral” rating to an “overweight” rating and decreased their price objective for the stock from $21.00 to $19.00 in a report on Wednesday, October 7th. Weiss Ratings cut shares of Afya from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday. Finally, Bank of America raised shares of Afya from a “neutral” rating to a “buy” rating and set a $16.00 target price on the stock in a research note on Thursday, October 29th. Three investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $17.00.

Afya Stock Up 1.8%

Shares of NASDAQ:AFYA opened at $10.64 on Friday. The stock’s 50-day moving average is $13.55 and its 200 day moving average is $14.18. The company has a market cap of $997.21 million, a PE ratio of 6.49, a P/E/G ratio of 1.24 and a beta of 0.34. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.20 and a quick ratio of 2.20. Afya has a 1 year low of $9.66 and a 1 year high of $16.16.

Afya (NASDAQ:AFYA) last released its quarterly earnings data on Friday, August 14th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.03. Afya had a return on equity of 17.58% and a net margin of 20.55%. The business had revenue of $187.80 million during the quarter, compared to analysts’ expectations of $189.62 million. Sell-side analysts anticipate that Afya will post 1.72 EPS for the current year.

Insider Activity at Afya

In related news, insider Santos Welder Ferreira sold 4,161 shares of Afya stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $13.30, for a total transaction of $55,341.30. Following the sale, the insider directly owned 35,000 shares in the company, valued at $465,500. The trade was a 10.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.80% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Afya

A hedge fund recently bought a new position in Afya stock. Engineers Gate Manager LP purchased a new stake in shares of Afya Limited (NASDAQ:AFYA) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 21,882 shares of the company’s stock, valued at approximately $325,000. Institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Limited is a medical education and digital health company focused on Brazil. Through its educational platform, the company provides undergraduate medical education, medical residency preparation, specialization and continuing medical education programs, and other learning resources for students and physicians.

Afya also offers digital products and services intended to support healthcare professionals throughout their careers. These include clinical content, study tools, telemedicine and practice-management solutions, and subscription-based applications designed to assist physicians with education, clinical decision-making, and patient care.

The company has expanded through the development and acquisition of medical schools, education businesses, and health technology platforms serving different stages of the medical professional lifecycle.